A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients

Pier Luigi Zinzani, Monica Tani, S. Fanti, V. Stefoni, Gerardo Musuraca, Paolo Castellucci, Enrica Marchi, Mohsen Farsad, Mariapaola Fina, Cinzia Pellegrini,

Annals of Oncology · 2008 · 86 citations · 21 references

DOIFull text

Open access

Concepts

References

21